Rapid infusion of rituximab with or without steroid-containing chemotherapy: 1-yr experience in a single institution
Author:
Publisher
Wiley
Subject
Hematology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0609.2006.00713.x/fullpdf
Reference7 articles.
1. Rituximab: Ongoing and future clinical development
2. Rituximab: Expanding Role in Therapy for Lymphomas and Autoimmune Diseases
3. Microgranular Variant (M3V) of Acute Promyelocytic Leukemia (APL) Does Not Have a Worse Prognosis than Classical APL in the Atra Era: A Report of 153 Patients Treated on Intergroup 0129 and Pethema LPA96 and LPA99.
Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Rapid rituximab administration: Safety of 60-minute infusions in malignant and benign haematological disease;Journal of Oncology Pharmacy Practice;2024-06-07
2. Safety and tolerability of a 90‐minute rapid infusion of Sandoz biosimilar rituximab in B‐cell lymphoproliferative disorders in a real‐world setting;Clinical and Translational Science;2022-11-24
3. Evaluation of a pharmacist-driven rapid infusion rituximab conversion protocol at a multisite cancer center;Journal of Oncology Pharmacy Practice;2020-12-09
4. Rapid rituximab infusion is safe and well tolerated in malignant and benign disease;Journal of Oncology Pharmacy Practice;2020-12-07
5. Clinical strategies for optimizing infusion center care through a pandemic;Journal of Oncology Pharmacy Practice;2020-09-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3